- Home
- GAIN vs NPCE Comparison
GAIN vs NPCE Comparison
Compare GAIN & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- NPCE
- Stock Information
- Founded
- GAIN 2005
- NPCE 1997
- Country
- GAIN United States
- NPCE United States
- Employees
- GAIN N/A
- NPCE N/A
- Industry
- GAIN Finance: Consumer Services
- NPCE Medical Specialities
- Sector
- GAIN Finance
- NPCE Health Care
- Exchange
- GAIN Nasdaq
- NPCE Nasdaq
- Market Cap
- GAIN 521.2M
- NPCE 424.1M
- IPO Year
- GAIN 2005
- NPCE 2021
- Fundamental
- Price
- GAIN $14.12
- NPCE $9.07
- Analyst Decision
- GAIN Hold
- NPCE Strong Buy
- Analyst Count
- GAIN 2
- NPCE 6
- Target Price
- GAIN $13.50
- NPCE $16.33
- AVG Volume (30 Days)
- GAIN 140.8K
- NPCE 370.2K
- Earning Date
- GAIN 08-12-2025
- NPCE 08-12-2025
- Dividend Yield
- GAIN 15.60%
- NPCE N/A
- EPS Growth
- GAIN N/A
- NPCE N/A
- EPS
- GAIN 1.78
- NPCE N/A
- Revenue
- GAIN $93,662,000.00
- NPCE $84,306,000.00
- Revenue This Year
- GAIN $5.34
- NPCE $21.04
- Revenue Next Year
- GAIN $5.29
- NPCE $10.73
- P/E Ratio
- GAIN $7.93
- NPCE N/A
- Revenue Growth
- GAIN 7.28
- NPCE 22.05
- 52 Week Low
- GAIN $11.42
- NPCE $5.45
- 52 Week High
- GAIN $15.34
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- GAIN 54.08
- NPCE 30.70
- Support Level
- GAIN $14.05
- NPCE $8.97
- Resistance Level
- GAIN $14.33
- NPCE $10.58
- Average True Range (ATR)
- GAIN 0.19
- NPCE 0.52
- MACD
- GAIN 0.02
- NPCE -0.03
- Stochastic Oscillator
- GAIN 64.29
- NPCE 9.41
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.